SnET2-PDT FDA Approval Status
FDA Approved: No
Brand name: SnET2-PDT
Generic name: Tin ethyl etiopurpurin (SnET2) photodynamic therapy (PDT)
Company: Miravant
Treatment for: Macular Degeneration
Development timeline for SnET2-PDT
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.